Mice homozygous for a disruption in the ␣-subunit essential for TSH, LH, and FSH activity (␣Gsu Ϫ/Ϫ ) exhibit hypothyroidism and hypogonadism similar to that observed in TSH receptor-deficient hypothyroid mice (hyt) and GnRH-deficient hypogonadal mutants (hpg). Although the five major hormone-producing cells of the anterior pituitary are present in ␣Gsu Ϫ/Ϫ mice, the relative proportions of each cell type are altered dramatically. Thyrotropes exhibit hypertrophy and hyperplasia, and somatotropes and lactotropes are underrepresented. The size and number of gonadotropes in ␣Gsu mutants are not remarkable in contrast to the hypertrophy characteristic of gonadectomized animals. The reduction in lactotropes is more severe in ␣Gsu mutants (13-fold relative to wild-type) than in hyt or hpg mutants (4.5-and 1.5-fold, respectively). In addition, T 4 replacement therapy of ␣Gsu mutants restores lactotropes to near-normal levels, illustrating the importance of T 4 , but not ␣-subunit, for lactotrope proliferation and function. T 4 replacement is permissive for gonadotrope hypertrophy in ␣Gsu mutants, consistent with the role for T 4 in the function of gonadotropes. This study reveals the importance of thyroid hormone in developing the appropriate proportions of anterior pituitary cell types. (Endocrinology 140: 1884 -1892, 1999) T HE MAJOR cell types of the anterior pituitary are distinguished by the hormones that they produce. TSH and the gonadotropins, LH and FSH, are heterodimeric glycoprotein hormones composed of a common ␣-subunit and unique ␤-subunits that confer specificity and bioactivity. Two functions of TSH are stimulation of the thyroid gland and thyroid folliculogenesis in the fetus. Likewise, LH and FSH play an integral role in gonadal differentiation in neonates (1) and are also regulators of sperm and ovarian development (2, 3). The gonadotropins and TSH are under feedback control by gonadal steroids and thyroid hormone, respectively. Feedback occurs both at the level of the hypothalamus and the pituitary gland.
T HE MAJOR cell types of the anterior pituitary are dis-
tinguished by the hormones that they produce. TSH and the gonadotropins, LH and FSH, are heterodimeric glycoprotein hormones composed of a common ␣-subunit and unique ␤-subunits that confer specificity and bioactivity. Two functions of TSH are stimulation of the thyroid gland and thyroid folliculogenesis in the fetus. Likewise, LH and FSH play an integral role in gonadal differentiation in neonates (1) and are also regulators of sperm and ovarian development (2, 3) . The gonadotropins and TSH are under feedback control by gonadal steroids and thyroid hormone, respectively. Feedback occurs both at the level of the hypothalamus and the pituitary gland.
Targeted disruption of the glycoprotein hormone ␣-subunit (␣Gsu or Cga) gene through homologous recombination in mouse embryonic stem cells was used to analyze the role of ␣-subunit, TSH, LH, and FSH in vivo (1) . ␣Gsu ϩ/Ϫ mice are normal and fertile, whereas ␣Gsu Ϫ/Ϫ mice exhibit hypothyroidism, hypogonadism, infertility, and severe growth deficiency. Although the ␣Gsu Ϫ/Ϫ mice have a normal lobular pituitary structure, there is a profound reduction in number of somatotropes and lactotropes as well as evidence of hyperplasia and hypertrophy of thyrotropes. Although the thyrotrope hyperplasia was expected, the near absence of lactotropes was not. Hypothyroidism usually leads to elevation of TRH, which results in stimulation of PRL production (4, 5) . One plausible explanation is that lactotrope differentiation is impaired due to the lack of secreted ␣-subunit monomers. This hypothesis is based on the observation that ␣-subunit stimulates PRL production in fetal pituitary cell cultures (6) . Alternatively, reduced PRL and GH production in response to the lack of steroid hormones and thyroid hormone, respectively, could be responsible. Finally, if thyrotropes, somatotropes, and lactotropes are derived from a common precursor, the hyperplasia of thyrotropes may deplete the precursor pool available for differentiation of the other cell types.
There are two other animal models that exhibit aspects of the ␣Gsu Ϫ/Ϫ phenotype. The arrested thyroid development of ␣Gsu Ϫ/Ϫ mice is comparable to the hypothyroid mutants (hyt), which lack a functional TSH receptor (7) . The hyt mice also exhibit hyperplasia and hypertrophy of thyrotropes with a decrease in the population of somatotropes (1, 8) . The hypogonadism and infertility of ␣Gsu Ϫ/Ϫ mice are reflective of the hypogonadal mutant (hpg), which has a deletion in the GnRH gene, effectively eliminating hypothalamic stimulation of pituitary gonadotropes (9) . Comparison of the pitu-itary cellular makeup of these mutants and that of ␣Gsu Ϫ/Ϫ mice supports the importance of thyroid hormone for lactotrope differentiation. T 4 replacement demonstrates that ␣-subunit is not required for PRL cell differentiation and that T 4 is critical for gonadotrope responsiveness to steroid hormone feedback control.
Materials and Methods Mice ␣Gsu
Ϫ/Ϫ mutants are embryonic stem cell-derived mice with a targeted mutation in the CG ␣ gene (Cga tm1 ). These mice were generated and maintained at the University of Michigan and have been deposited in the Induced Mutant Resource at The Jackson Laboratory (Bar Harbor, ME) (1). The hyt and hpg mice were provided by The Jackson Laboratory. All procedures using mice were approved by the University of Michigan Committee on Use and Care of Animals. All experiments were conducted in accordance with the principles and procedures outlined in the NIH Guidelines for the Care and Use of Experimental Animals.
PCR screening of ␣Gsu
Ϫ/Ϫ mutants ␣Gsu Ϫ/Ϫ mutants were detected by PCR analysis of genomic DNA prepared from tail biopsies as previously described (1) . Two sets of primers were used, one to amplify the ␣Gsu Ϫ/Ϫ allele and another to amplify the wild-type allele.
TSH RIA
TSH was measured by a mouse specific double antibody RIA using a mouse TSH/LH reference preparation (AFP51718mp), a mouse TSH antiserum (AFP98991), and rat TSH antigen for radioiodination (NIDDK rTSH-I-9). All reagents were obtained from Dr. A. F. Parlow (Harbor University of California-Los Angeles Medical Center, Torrance, CA). For each serum sample, duplicate determinations were made in parallel on 25-l aliquots of serum. The limit of sensitivity was 0.6 ng, and the intraassay variation less than 6% (10, 11) . Equivalent amounts of hyperthyroid mouse serum were added to the standard tubes. Enzymatic iodination of the NIDDK rTSH-I-9 preparation was achieved by the glucose oxidase/lactoperoxidase technique (12) . After labeling [ 125 I]rTSH was purified by concanavalin A-Sepharose adsorption and stored in aliquots at Ϫ80 C. The tracer was further purified by high resolution gel filtration with Sephadex G-100 performed immediately before use.
Thyroid hormone treatment
Two approaches to thyroid replacement therapy were taken. First, adult ␣Gsu Ϫ/Ϫ mice at 56 days (8 weeks) of age were injected daily with 2.0 g T 4 (Sigma T-0397) for 40 days. This regimen is similar to one previously described (13, 14) . Second, neonates were fed a special chow supplemented with powdered thyroid glands (250 mg thyroid powder/kg chow) for 8 weeks. The thyroid chow was obtained from Amersham (Arlington Heights, IL). All mice were weighed on an Ohaus GA110 scale once a week (Ohaus, Union, NJ). Measurements were segregated according to phenotype, sex, and type of treatment. The average and sd of the mean were calculated for each group. The unpaired t test was applied to weight data collected from normal mice (ϩ/Ϫ and ϩ/ϩ; n ϭ 8, 4 females and 4 males), untreated Ϫ/Ϫ mice (n ϭ 7; 2 females and 5 males), Ϫ/Ϫ mice injected with T 4 (n ϭ 7; 3 females and 4 males), and Ϫ/Ϫ mice fed thyroid chow (n ϭ 8; 3 females and 5 males) and their normal littermates fed the same diet (ϩ/ϩ and ϩ/Ϫ; n ϭ 21; 10 females and 11 males). Mice were killed at the end of treatment, and pituitaries of all the mice were removed and analyzed by immunohistochemistry. Seven additional male Ϫ/Ϫ mice (4 months) were included in the immunohistochemical analysis to enhance the statistical significance of the quantitation (15) .
Injection of 4-month-old mice with 2.0 g T 4 (Sigma T-0397) was also performed. Injections occurred once a day for 3 days, after which the mice were killed, and pituitaries were removed and analyzed (n ϭ 4).
Pituitary histology and immunohistochemistry
Pituitaries were removed and fixed in 4% paraformaldehyde, pH 7.2, for 3-4 h and embedded in paraffin 3-m sections and immunostained with antibodies to five of the pituitary hormones followed by counterstaining with hematoxylin. Gill's formulation 3 hematoxylin was obtained from Fisher Scientific (Pittsburgh, PA). Pituitaries were immunostained with polyclonal antiserum against rat GH (1:1000 dilution), rat LH␤ (1:2000), rat TSH␤ (1:1000), rat PRL (1:2000) , and human ACTH (1:1000) and counterstained with hematoxylin. All antisera except ACTH antiserum were donated by the National Hormone and Pituitary Program, NIDDK (Bethesda, MD). ACTH antiserum was obtained from DAKO Corp. (Santa Barbara, CA). Biotinylated secondary antibodies were used in conjunction with avidin and biotinylated peroxidase (Vectastain guinea pig, rabbit, human kits, Burlingame, CA). Diaminobenzidine was used as the chromogen resulting in brown staining.
The percentages of the GH, LH, and PRL cell types in the pituitary were counted under ϫ40 brightfield illumination with a reticular eyepiece (1-mm 2 grid area). The total number of cells and the positively stained cells were counted separately within each grid area. At least 1500 cells were counted and at least 3 different fields were examined in each animal. The numbers from multiple grid counts were tallied, and the percentage of positively stained cells was calculated. The following sets of mice were quantitated: 2 females and 1 male, ϩ/ϩ; 1 female and 8 males, untreated Ϫ/Ϫ; 2 females and 3 males, Ϫ/Ϫ injected with T 4 ; and 4 females and 3 males, Ϫ/Ϫ raised on thyroid chow.
Morphometric analysis
The diameter of 50 thyrotropes was measured in photographs of pituitary sections from ϩ/ϩ and Ϫ/Ϫ mice. For each thyrotrope, two measurements were taken at the widest part of the cell at 90°angles to one another. The average diameter (12.4 Ϯ 2.8 m for Ϫ/Ϫ and 6.6 Ϯ 1.3 m for ϩ/ϩ) was used to calculate the area (A ϭ r 2 ) and volume (V ϭ 4/3 r 3 ) of each cell.
RNA analysis
Pituitaries from ␣Gsu Ϫ/Ϫ and ␣Gsu ϩ/ϩ mice were collected and pooled according to genotype. RNA was purified using the either the Trizol prep (Life Technologies, Grand Island, NY) or the RNAzol prep (16) . Three to 5 g RNA were loaded into each lane of a 1.5% agarose gel and electrophoresed in 1 ϫ 3-[N-morpholino]propanesulfonic acid buffer at 80 mA for 6 -10 h. The RNA was transferred overnight onto a Zeta-Probe Blotting Membrane (Bio-Rad Laboratories, Inc., Hercules, CA). Filters were hybridized with [␣-32 P]deoxy-CTP-labeled mouse TSH␤, LH␤, PRL, GH, rat POMC, FSH␤, and mouse ␤-actin (see below) at 65 C overnight, then washed to a stringency of 0.1 ϫ SSC (standard saline citrate)-0.1% SDS at 57-65 C (17) . Filters were exposed on film for up to 2 weeks or to PhosphorImager screens overnight (Molecular Dynamics, Sunnyvale, CA). Quantitation was carried out with a PhosphoImager (Molecular Dynamics, Sunnyvale, CA). This experiment was repeated with independent RNA preparations. Filters were stripped by soaking in boiled 1% SDS-0.1 ϫ SSC and 40 mm Tris-Cl, pH 7.5. Blots were normalized assuming that the ␤-actin hybridization signal from ϩ/ϩ and Ϫ/Ϫ pituitary RNA samples should be the same.
The complementary DNA (cDNA) probes used for Northern analysis were provided by Richard Maurer (FSH␤, rPRL), David Gordon and E. Chester Ridgway (mouse TSH␤), John Nilson (mouse LH␤), and Michael J. Dixon (rat POMC). The mouse GH probe consists of 802 bp spanning from 59 bp upstream of the ATG to 41 bp downstream of the stop codon. The rat PRL probe is a 735-bp cDNA fragment including most of the 5Ј-untranslated region, the complete coding region, and a portion of the 3Ј-untranslated region. The 874-bp rat FSH␤ cDNA probe contains the complete coding sequence. The POMC probe is a 900-bp cDNA fragment isolated by PCR amplification. The TSH␤ probe is a 496-bp HindII-EcoRI fragment of the mTSH␤ cDNA cloned into pGEM3. The LH␤ probe was generated from a 250-bp fragment of the mouse LH␤ cDNA isolated by PCR amplification and cloned into pBSK Ϫ . Mouse ␤-actin is from CLONTECH Laboratories, Inc. (Palo Alto, CA).
Results

TSH-deficient ␣Gsu
Ϫ/Ϫ mice exhibit thyrotrope hypertrophy and hyperplasia ␣Gsu Ϫ/Ϫ mice are devoid of ␣-subunit messenger RNA (mRNA) and protein (1) . Heterodimer formation between TSH␤ and ␣-subunit is essential for ␤-subunit secretion (18 -21) . Therefore, it was not expected that TSH␤ could be secreted in the absence of ␣-subunit. No TSH was detectable in the serum of ␣Gsu Ϫ/Ϫ mice by RIA (Ͻ20 ng/ml, n ϭ 3 Ϫ/Ϫ mice; 86.4 Ϯ 2.9 ng/ml, n ϭ 3 ϩ/ϩ mice). In addition, no secretory granules were evident in thyrotropes of Ϫ/Ϫ mice examined by electron microscopy (data not shown). T 4 was also undetectable in the serum of ␣Gsu Ϫ/Ϫ mice by RIA, consistent with the lack of TSH stimulation (1).
The cellular composition of ␣Gsu Ϫ/Ϫ mouse pituitaries is distorted relative to that of normal mice (1) . Thyrotrope hypertrophy and extensive, diffuse hyperplasia were present in 2-month-old mutants (Fig. 1) . Morphometric analysis revealed that the average diameter of the thyrotropes in Ϫ/Ϫ mice was increased approximately 1.9-fold relative to that of ϩ/ϩ mice (12.4 Ϯ 2.8 and 6.68 Ϯ 1.3 m, respectively), resulting in a 6.8-fold increase in cell volume. Despite this increase in volume and the dramatic hyperplasia of thyrotropes, pituitaries of ␣Gsu Ϫ/Ϫ mice weigh approximately the same as those of normal mice at 2 months of age (2 mg average; data not shown). Therefore, the increase in thyrotrope size and number must occur at the expense of other cell types. Both GH-and PRL-producing cells appear to be profoundly reduced in number by immunohistochemistry ( Figs.  1 and 2) .
The reduction in lactotropes (PRL) and somatotropes (GH) was quantitated by cell counts (Fig. 3) . In wild-type pituitaries, an average of 38% and 49% of the cells immunostained with PRL and GH antibodies, respectively. In ␣Gsu Ϫ/Ϫ mice, lactotropes and somatotropes averaged only 3% and 12.5% of the cells, representing 13-and 4-fold reductions, respectively. The modest increase in gonadotropes in ␣Gsu Ϫ/Ϫ mice relative to control values was not statistically significant (7% vs. 5.2%, respectively).
Northern analysis was performed to determine whether the alterations in immunostaining between ϩ/ϩ and Ϫ/Ϫ corresponded to changes in steady state levels of mRNA. The PRL mRNA levels in ␣Gsu Ϫ/Ϫ mice were reduced to 0.27% of those in normal mice (Fig. 4) . GH mRNA levels in Ϫ/Ϫ pituitaries were only 7.9% of the normal levels. The FSH␤ and LH␤ mRNA levels were similar to those in ϩ/ϩ mice (174% and 106%, respectively), and POMC mRNA levels were slightly reduced (mutants were 39% of normal).
Thyroid hormone treatment alleviates ␣Gsu
Two thyroid hormone replacement regimens were conducted to test whether thyrotrope hypertrophy and hyperplasia could be prevented or reversed. Neonates were given a thyroid hormone-supplemented diet for 8 weeks to prevent dwarfism and the onset of thyrotrope hypertrophy and hyperplasia (n ϭ 8), and 8-week-old ␣Gsu Ϫ/Ϫ mutants (n ϭ 7) were injected with T 4 every day for 40 days in an attempt to reverse the established phenotype (13, 14) . Both treatments relieved the proportionate dwarfism characteristic of ␣Gsu Ϫ/Ϫ mutants, indicating that both regimens are effective ( Fig. 5 and Table 1 ). The catch-up growth stimulated by thyroid hormone treatment of 2-month-old mice resulted in an 86% weight gain over the 40-day treatment period compared with the modest gain of untreated mutants (16 -18%). After treatment, the weights of male and female ␣Gsu Ϫ/Ϫ mice were equivalent to those of female control mice. Male control mice were heavier than female controls and ␣Gsu Ϫ/Ϫ mice of both sexes as expected due to the hypogonadism of the ␣Gsu Ϫ/Ϫ mice (1). The size and weight of ␣Gsu
neonates fed thyroid hormone in their chow was indistinguishable from those of their normal female littermates at 8 weeks (P Ͼ 0.1) and slightly less than those of their male littermates (P Ͻ 0.05; Table 1 ).
Thyroid hormone treatment normalizes pituitary cellular makeup
Thyroid hormone-treated ␣Gsu Ϫ/Ϫ mice showed reduced production of TSH␤ by immunohistochemistry (Fig. 1) . T 4 -treated adults contained TSH␤-staining cells that appeared shrunken relative to those of untreated adult ␣Gsu Ϫ/Ϫ mice. Treatment with T 4 from birth profoundly reduced the number of TSH␤-staining cells. Thyrotropes were rare in these mice relative to those in normal mice. Both thyroid hormone replacement regimens resulted in striking gonadotrope hypertrophy, as illustrated by the LH␤ antibody staining, and each treatment increased gonadotrope cell number significantly relative to untreated ␣Gsu Ϫ/Ϫ mice (Fig. 3) . The GH and PRL immunostaining suggested that both T 4 treatments substantially increased the somatotrope and lactotrope cell numbers in ␣Gsu Ϫ/Ϫ mice ( Figs. 1 and 2 ), and the cell counts corroborated this (Fig. 2) . Somatotrope cell numbers in T 4 -treated ␣Gsu Ϫ/Ϫ mice were indistinguishable from normal values. Lactotrope numbers were dramatically improved (23% and 26% in treated adults and neonates), but they remained slightly less than normal (38%).
The increase in PRL and GH cells in ␣Gsu Ϫ/Ϫ mice after 40 days of T 4 treatment could be attributable to differentiation from precursor cells. Alternatively, T 4 treatment may have enhanced hormone production or storage in differentiated cells already present but inactive. To distinguish between these possibilities, a 3 day T 4 treatment was performed. Four ␣Gsu Ϫ/Ϫ mice were injected with T 4 . Immunostaining for TSH, PRL, GH, and LH revealed no difference between the untreated mice and the 3-day treated mice (data not shown). Thyrotropes remained hypertrophic and hyperplastic. PRL cell counts were similar in the 3-day treated ␣Gsu Ϫ/Ϫ mutants (2.9%) and untreated ␣Gsu Ϫ/Ϫ mutants mice (3%). This result suggests that few inactive lactotropes are present.
Lactotrope content is reduced more in hypothyroid mice than in hypogonadal mice
The pituitaries of ␣Gsu Ϫ/Ϫ mice were compared with TSH receptor-deficient hypothyroid (hyt) and GnRH-deficient hypogonadal (hpg) mutants. Hypothyroid hyt/hyt mice had fewer somatotropes than normal mice (33% vs.
FIG. 1. Treatment of ␣Gsu
Ϫ/Ϫ mice with thyroid hormone restores somatotrope and lactotrope cell populations to nearly normal and induces gonadotrope hypertrophy. Sections of pituitaries from young adult (2-3.5 months old) ϩ/ϩ and ␣Gsu Ϫ/Ϫ mice without T 4 treatment, adult ␣Gsu Ϫ/Ϫ injected for 40 days with T 4 , and ␣Gsu Ϫ/Ϫ given a thyroid hormone-supplemented diet from birth for 8 weeks were immunostained with the antibodies to TSH␤, LH␤, GH, and PRL and counterstained with hematoxylin. Scale bar, 25 m. n ϭ 8 for mice fed thyroid hormone chow, n ϭ 5 for Ϫ/Ϫ T 4 injected mice, and n ϭ 3 ϩ/ϩ and 7 Ϫ/Ϫ for untreated mice. Representative examples are illustrated. 49%), but more than untreated ␣Gsu Ϫ/Ϫ mutants (12.5%). Both the hypothyroid hyt/hyt and the hpg/hpg mice have fewer lactotropes (7% and 25%, respectively) than normal mice (38%). Neither the hpg nor the hyt mutants had as severe a reduction in lactotropes as the ␣Gsu Ϫ/Ϫ mice (3%). This suggests that both thyroid hormone and steroid hormones are important for normal lactotrope numbers and that the requirement for thyroid hormone is stronger than the requirement for gonadal steroids.
Discussion
Disruption of the pituitary ␣-subunit gene has a dramatic impact on pituitary cellular composition
Disruption of the pituitary ␣-subunit gene caused a lack of gonadotropins and TSH, which resulted in hypogonadism, hypothyroidism, and proportionate dwarfism (1). The cellular composition of the anterior pituitary was altered dramatically. Although lactotropes normally represent 38% of the total cells, very few PRL-producing cells were detectable by immunohistochemistry in the knockout mice (3%). In addition to reduced PRL protein, PRL mRNA was reduced to 0.27% of normal levels. Somatotropes, another of the most abundant cell types in normal pituitaries (49%), were reduced to 12.5% of the total, and GH mRNA was reduced as well (7.9% of normal). These data suggest that the targeted mutation affected PRL and GH gene transcription and protein accumulation. The predominant pituitary cell type in ␣Gsu mutants was the thyrotrope. These cells displayed both dramatic hypertrophy (ϳ7-fold increase in cell volume) and diffuse hyperplasia throughout the pituitary gland. Thyroid hormone deficiency induced by thyrotoxic drugs also induces hypertrophy and hyperplasia, but the hyperplasia is limited to discrete foci within the gland (1, 8) . The proportion of gonadotropes and corticotropes was not substantially changed, and the levels of LH, FSH, and POMC mRNA were similar (within 2-to 3-fold) in mutants and wild-type mice.
There were several plausible explanations for the expan- . On experimental day 1, the weights of the treated and untreated ␣Gsu Ϫ/Ϫ mice were significantly less than those of the normal males and females (P Ͻ 0.0001). By day 23, the T 4 -treated males and females had grown and weighed significantly more than the untreated ␣Gsu Ϫ/Ϫ mice, but they still weighed much less than the normal males (P ϭ 0.0001) and slightly less than the normal females (P Ͻ 0.05). By day 40, there was no difference between the size of the normal females and the T 4 -treated ␣Gsu Ϫ/Ϫ mice (P ϭ 0.37), but the normal males were significantly larger than either the untreated or T 4 -treated ␣Gsu Ϫ/Ϫ mice (P Ͻ 0.0001 and P Ͻ 0.01, respectively).
sion of thyrotropes and the reduction in both somatotropes and lactotropes. First, congenital hypothyroidism impacts thyroid development during gestation (1, 7), potentially stimulating expansion of thyrotropes early enough to cause pituitary-wide hyperplasia. In contrast, hypothyroidism induced in older mice may only induce focal hyperplasia because of a reduction in the proliferative capacity of thyrotropes with age. Several lines of evidence support the derivation of thyrotropes, lactotropes, and somatotropes from a common precursor cell (22); thus, it is possible that the massive recruitment of thyrotropes during gestation reduces the precursor pool available for differentiation into the other two cell types. A second possibility is based on the fact that PRL production and lactotrope proliferation are stimulated by estrogen, and GH production is stimulated by thyroid hormone (23, 24) . Thus, the hypogonadism and hypothyroidism and the resulting lack of estrogen and thyroid hormone could have caused the reduction in lactotropes and somatotropes, respectively. Third, several laboratories have demonstrated that ␣-subunit stimulates lactotrope differentiation (6, 25) , opening the possibility that the dramatic impact on lactotropes was caused by the disruption of the ␣-subunit gene. To assess the potential contribution of each of these factors to pituitary cell content, we carried out thyroid hormone replacement and compared the pituitary cell content of the ␣Gsu mutants to mice with either congenital hypogonadism or hypothyroidism.
Thyroid hormone replacement normalizes pituitary cellular makeup
Thyroid hormone replacement rescued the proportionate dwarfism, prevented and reversed thyrotrope hypertrophy and hyperplasia, and normalized the number of lactotropes and somatotropes. Administration of thyroid hormone by ip injection of young adult mice for 40 days partially reversed the thyrotrope hypertrophy and hyperplasia. Newborns whose mothers were fed thyroid hormone-supplemented chow and who were fed the same chow after weaning had normalized somatotropes and lactotropes and very few thyrotropes at 40 days of age. However, a 3-day thyroid hormone replacement regimen was not effective in inducing PRL production. If thyroid hormone were able to induce existing lactotrope cells in the ␣Gsu Ϫ/Ϫ mice to synthesize PRL mRNA and protein, then the 3-day T 4 replacement regimen would have been expected to be more effective. Transgene ablation studies have shown that renewal of depleted lactotropes from precursor pools in adult mice requires 3-6 weeks (26) . Thus, the observed establishment of PRL production in 40 days is consistent with significant differentiation of lactotropes from precursor cells. The fact that thyroid hormone alone was effective in normalizing pituitary cellular makeup suggests that somatotropes and lactotropes require T 4 for differentiation.
Thyroid hormone is important for lactotrope differentiation
Comparison of pituitary cell content in hypothyroid, hyt, hypogonadal, and ␣Gsu Ϫ/Ϫ mutants supports the reliance of PRL and GH cells on T 4 . The hyt/hyt mutants exhibit hypertrophy and hyperplasia of thyrotropes and a decrease in the number of somatotropes (8) . Using immunohistochemistry, we have shown that hyt/hyt mutants also have a profound reduction in the number of lactotropes (7% of the cells are lactotropes), supporting the critical role of thyroid hormone in lactotrope differentiation or proliferation. The hpg/hpg mutants cannot produce GnRH, which results in a severe reduction in pituitary gonadotropins, hypogonadism and low circulating levels of gonadal steroids. These mice have only slightly reduced lactotrope cell numbers (26% of the total cells are lactotropes) despite the established role of estrogen in stimulating lactotrope proliferation (27) . In addition, the lactotropes in hypogonadal mice generated by transgene ablation of gonadotropes are only reduced to 29% of wildtype levels (28) . The slight reduction in lactotropes in hpg/hpg and T 4 -treated ␣Gsu Ϫ/Ϫ mutants is probably a secondary effect due to the lack of normal pubertal maturation during which estrogen stimulates PRL proliferation (29) . These data demonstrate that an intact pituitary-thyroid axis is essential for the differentiation or proliferation of PRL-producing cells. Although all of these data suggest that thyroid hormone is more important for initiating lactotrope differentiation than gonadal steroids, recent studies suggest that 2 months of estrogen treatment can stimulate lactotrope differentiation in thyroid hormone-deficient ␣Gsu Ϫ/Ϫ mice (15). The impaired differentiation of lactotropes in the context of hypothyroidism is somewhat surprising, given that TRH stimulates PRL production and lactotrope proliferation (30) . The lack of thyroid hormone might be expected to cause chronic elevation of TRH and eventually lead to prolactinomas. Instead, the hyt and ␣Gsu mice both have profound deficiencies in lactotropes. Thyroid hormone may be required as a priming event to set up the TRH responsiveness of lactotropes or to regulate expression of a gene that promotes lactotrope differentiation. Another possibility is that lineage relationships between the cells exert an influence during ontogeny that is not evident in mature animals.
Transgene ablation studies have supported the derivation of lactotropes from somatotropes (26, 31) via an intermediate cell type that produces both PRL and GH (26) . Severe mutations in Pit1 ablate three cell types, thyrotropes, somatotropes, and lactotropes (32, 33) , supporting the idea that these three cells arise from a common precursor. Although intermediate cells expressing both GH and TSH have been observed (34), ablation of thyrotropes by diphtheria toxin had no impact on somatotrope differentiation, nor does ablation of somatotropes effect thyrotropes (17, 26, 31) . This suggests that establishment of a normal component of somatotropes and lactotropes does not require functional thyrotropes (17) . On the surface, the apparent independence of the thyrotrope and somatotrope-lactotrope lineages in ablation experiments appears in conflict with the dependence of lactotropes on functional thyrotropes in ␣Gsu Ϫ/Ϫ mice. Perhaps, recruitment of thyrotropes from a common precursor pool depletes the pool available for generation of lactotropes. As lactotropes are thought to be derived primarily from somatotropes, it is reasonable to expect that the consequences for lactotropes would be more severe than those for somatotropes. Further studies will be required to understand the mechanism of thyroid hormone stimulation of lactotrope differentiation and the ability of estrogen replacement to stimulate lactotropes in thyroid hormone-deficient animals (15) .
␣-Subunit is not required for lactotrope differentiation
␣-Subunit is expressed early in anterior pituitary development, several days before the expression of the ␤-subunits (35, 36) . ␣-Subunit protein is secreted as a monomer with a different glycosylation pattern than when it is heterodimerized with ␤-subunit (37). Free ␣-subunit acts as an inducer of lactotrope differentiation and PRL secretion (6, 25, 38, 39) . Consistent with the idea that ␣-subunit has growth-stimulating properties, the ␣-subunit crystal structure reveals that it has a cysteine knot tertiary structure similar to nerve growth factor, transforming growth factor, and plateletderived growth factor (40) . The deficiency in lactotropes in ␣Gsu Ϫ/Ϫ mice initially supported the idea that ␣-subunit might be critical for lactotrope differentiation. We have demonstrated that lactotropes can be rescued efficiently by T 4 administration even though the ␣Gsu Ϫ/Ϫ mice are hypogonadal and estrogen deficient. Because the thyroid hormonetreated mice are genetically unable to produce ␣-subunit, it is clear that free ␣-subunit is not necessary for the differentiation and proliferation of lactotropes. Although these experiments demonstrate that ␣-subunit is not required, we cannot rule out the possibility that ␣-subunit normally plays a role in stimulating lactotrope differentiation. Many growth factors and peptides, including nerve growth factor, transforming growth factor, cytokines, and fragments of POMC, have also been shown to effect lactotrope differentiation (41) (42) (43) (44) (45) (46) . Thus, alteration in the synthesis or secretion of these or other factors in the mutant mice may compensate for the lack of ␣-subunit. Direct replacement of ␣-subunit will be necessary to determine whether it is sufficient for stimulation of lactotropes in hypothyroid, hypogonadal mice.
Gonadotropes need thyroid hormone for feedback responsiveness
It has been well established that hyperplasia and hypertrophy of gonadotropes occur in response to gonadectomy (47, 48) . Presumably, gonadectomy results in the loss of gonadal steroid feedback to the pituitary, which causes an increase in the synthesis and secretion of LH and FSH and an expansion in gonadotrope cell area (47) . GnRH-treated hpg mice also exhibit enlarged gonadotrope cells (49) . In contrast, the lack of functional LH and FSH in ␣Gsu Ϫ/Ϫ mice did not cause gonadotrope hypertrophy. However, T 4 -treated ␣Gsu Ϫ/Ϫ mice exhibited remarkable gonadotrope hypertrophy. This suggests that T 4 is required to establish the sensitivity of gonadotropes to feedback regulation by gonadal steroids.
The ovaries and uteri of ␣Gsu Ϫ/Ϫ females were responsive to gonadotropin and estrogen treatments, respectively (data not shown). The ovaries of older ␣Gsu Ϫ/Ϫ females contained hemorrhagic cysts. It is well established that an iodine-poor diet induces cystic ovaries; thus, the cysts in the ␣Gsu mutants probably resulted from the hypothyroid state (50 -52) .
Conclusion
Our studies with the ␣Gsu Ϫ/Ϫ mice have demonstrated that ␣-subunit is not required for pituitary lactotrope differentiation or PRL production. Instead, T 4 is critical for developing a normal component of PRL and GH cells. T 4 also appears to be important, directly or indirectly, for priming the responsiveness of gonadotropes to steroid hormone feedback. The mechanism for T 4 action as a permissive factor for these three pituitary cell types will be an important area for future investigation.
